MACKENZIE FINANCIAL CORP
Position in EBS — Emergent BioSolutions Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in EBS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$817,150
+$585,777 QoQ
Shares Held
97,512
+2010.2% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 194 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. EBS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in EBS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $817,150 | 97,512 | Shares | Sole | 2026-08-13 | |
| 2021-09-30 | $231,373 | 4,621 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $227,834 | 3,617 | Shares | Sole | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||